Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

INDERIDE LA 120/50

HYDROCHLOROTHIAZIDE; PROPRANOLOL HYDROCHLORIDE

Standard Dose
50MG;120MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview INDERIDE LA 120/50 is listed in Drugs@FDA under application 019059 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient HYDROCHLOROTHIAZIDE; PROPRANOLOL HYDROCHLORIDE Form and strength CAPSULE, EXTENDED RELEASE;ORAL - 50MG;120MG Sponsor WYETH AYERST Submission history Latest submission status date: 2001-11-01 00:00:00.

Structured Monograph

Clinical summary

Approval overview INDERIDE LA 120/50 is listed in Drugs@FDA under application 019059 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient HYDROCHLOROTHIAZIDE; PROPRANOLOL HYDROCHLORIDE Form and strength CAPSULE, EXTENDED RELEASE;ORAL - 50MG;120MG Sponsor WYETH AYERST Submission history Latest submission status date: 2001-11-01 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.